Dan Salthouse Peter Goulding Sophie Reay Emma Jackson Professor Katarina Novakovic et al. | Amine-reactive crosslinking enhances type 0 collagen hydrogel properties for regenerative medicine | 2024 |
|
Dr Luke Milross Bethany Hunter Dr David McDonald George Merces Dr Amanda Thomson et al. | Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19 | 2024 |
|
Bethany Hunter Ioana Nicorescu Emma Foster Dr David McDonald Dr Gill Hulme et al. | OPTIMAL: An OPTimized Imaging Mass cytometry AnaLysis framework for benchmarking segmentation and data exploration | 2024 |
|
Professor Catharien Hilkens Julie Diboll Dr Fiona Cooke Dr Amy Anderson
| In vitro generation of human tolerogenic monocyte-derived dendritic cells | 2023 |
|
Professor Catharien Hilkens
| Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration | 2023 |
|
Sophie Reay Emma Jackson Dan Salthouse Dr Ana Ferreira-Duarte Professor Catharien Hilkens et al. | Effective Endotoxin Removal from Chitosan That Preserves Chemical Structure and Improves Compatibility with Immune Cells | 2023 |
|
Dan Salthouse Professor Katarina Novakovic Professor Catharien Hilkens Dr Ana Ferreira-Duarte
| Interplay between biomaterials and the immune system: Challenges and opportunities in regenerative medicine | 2023 |
|
Ayesha Sahar Ioana Nicorescu Professor Catharien Hilkens Dr Phillip Lord
| Tolerogenic dendritic cell reporting: Has a minimum information model made a difference? | 2023 |
|
Sophie Reay Emma Jackson Dr Ana Ferreira-Duarte Professor Catharien Hilkens Professor Katarina Novakovic et al. | In vitro evaluation of the biodegradability of chitosan–genipin hydrogels | 2022 |
|
Dr Fiona Cooke Dr Mary Neal Dr Matthew Wood Dr Amy Anderson Julie Diboll et al. | Fluorine labelling of therapeutic human tolerogenic dendritic cells for 19F-magnetic resonance imaging | 2022 |
|
Professor John Isaacs Sarah Brockbank Dr Ayako Pedersen Professor Catharien Hilkens Dr Amy Anderson et al. | RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients | 2022 |
|
Professor Katarina Novakovic Sophie Reay Dr Ana Ferreira-Duarte Professor Catharien Hilkens
| Towards biocompatible pulsatile materials | 2022 |
|
Dr Fiona Rayner Dr Amy Anderson Dr Ken Baker Professor Christopher Buckley Dr Bernard Dyke et al. | BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study | 2021 |
|
Leonie Schittenhelm Dr Arthur Pratt Professor Catharien Hilkens
| Dendritic cell integrin expression patterns regulate inflammation in the rheumatoid arthritis joint | 2021 |
|
Professor Catharien Hilkens Professor Paul Garside
| Preclinical models of arthritis for studying immunotherapy and immune tolerance | 2021 |
|
Dr Amanda Thomson Professor Catharien Hilkens
| Synovial Macrophages in Osteoarthritis: The Key to Understanding Pathogenesis? | 2021 |
|
Dr Matthew Wood Adam Leckenby Dr Gary Reynolds Dr Rachel Spiering Dr Arthur Pratt et al. | Macrophage proliferation distinguishes 2 subgroups of knee osteoarthritis patients | 2019 |
|
Dr Rachel Spiering Professor Catharien Hilkens
| Matured tolerogenic dendritic cells effectively inhibit autoantigen specific CD4+ T cells in a murine arthritis model | 2019 |
|
Dr Rachel Spiering Matthew Wood Anshor Fath Oliver Eltherington Dr Amy Anderson et al. | Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis | 2019 |
|
Professor Catharien Hilkens
| Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective | 2019 |
|
Dr Rachel Spiering Professor John Isaacs Professor Catharien Hilkens Dr Phillip Lord
| Minimum information about T regulatory cells: A step toward reproducibility and standardization | 2018 |
|
Dr Faye Cooles Dr Amy Anderson Andrew Skelton Dr Arthur Pratt Professor Iain McInnes et al. | Phenotypic and transcriptomic analysis of peripheral blood plasmacytoid and conventional dendritic cells in early drug naïve rheumatoid arthritis | 2018 |
|
Dr Rachel Spiering Professor John Isaacs Professor Catharien Hilkens
| Targeting of tolerogenic dendritic cells towards heat-shock proteins: A novel therapeutic strategy for autoimmune diseases? | 2018 |
|
Dr Aisha Blfgeh Dr Jennifer Warrender Professor Catharien Hilkens Dr Phillip Lord
| A document-centric approach for developing the tolAPC ontology | 2017 |
|
Dr Gillian Bell Dr Amy Anderson Julie Diboll Oliver Eltherington Dr Rachel Harry et al. | Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis | 2017 |
|
Professor Catharien Hilkens
| Cell-based tolerogenic therapy, experience from animal models of multiple sclerosis, type 1 diabetes and rheumatoid arthritis | 2017 |
|
Dr Faye Cooles Dr Amy Anderson Dr Dennis Lendrem Julie Norris Dr Arthur Pratt et al. | The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy | 2017 |
|
Dr Amy Anderson Dr David Swan Oliver Eltherington Dr Arthur Pratt Dr Gary Reynolds et al. | Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4+ T-cells partly via TGF-β1 | 2017 |
|
Joseph Cowell Matthew Buck Rebecca Clarke Professor Waldemar Vollmer Dr Daniela Vollmer et al. | Traceless-Cleavage of Protein-Biotin Conjugates Under Biologically-Compatible Conditions | 2017 |
|
Dr Tom Clifford Matt Wood Philip Stocks Professor Emma Stevenson Professor Catharien Hilkens et al. | T-regulatory cells exhibit a biphasic response to prolonged endurance exercise in humans | 2017 |
|
Leonie Schittenhelm Professor Catharien Hilkens
| β2 Integrins As Regulators of Dendritic Cell, Monocyte, and Macrophage Function | 2017 |
|
Dr Aisha Blfgeh Dr Jennifer Warrender Professor Catharien Hilkens Dr Phillip Lord
| A document-centric approach for developing the tolAPC Ontology | 2016 |
|
Dr Katherine Crossland Dr Mario Abinun Professor Timothy Cheetham Professor Simon Pearce Professor Catharien Hilkens et al. | AIRE is not essential for the induction of human tolerogenic dendritic cells | 2016 |
|
Professor Ioakim Spyridopoulos Dr Carmen Martin-Ruiz Professor Catharien Hilkens Mohammad Yadegarfar Professor John Isaacs et al. | CMV-seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians - results from the Newcastle 85+ study | 2016 |
|
Professor Catharien Hilkens
| Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic Properties on Naive and Memory CD4+ T Cells | 2016 |
|
Dr Phillip Lord Dr Rachel Spiering Dr Amy Anderson Julie Diboll Emeritus Professor Lindsay Marshall et al. | Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies | 2016 |
|
Dr Phillip Lord Professor Catharien Hilkens
| Ontology in Immunology | 2016 |
|
Chris Tibbitt Dr Jane Falconer Dr Jeroen Stoop Emeritus Professor John Robinson Professor Catharien Hilkens et al. | Reduced TCR-dependent activation through citrullination of a T-cell epitope enhances Th17 development by disruption of the STAT3/5 balance | 2016 |
|
Dr Gary Reynolds Dr Arthur Pratt Dr David Coady Dr Graham Raftery Dr Alice Lorenzi et al. | Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis | 2016 |
|
Professor Catharien Hilkens
| Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features | 2016 |
|
Dr Gary Reynolds Dr Paul Milne Dr Venetia Bigley Professor Matthew Collin Professor John Isaacs et al. | Use of the dendritic cell marker, B and T lymphocyte attenuator, to identify functionally distinct subsets of human CD1c+ dendritic cells | 2016 |
|
Professor Catharien Hilkens Dr Phillip Lord
| Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort | 2015 |
|
Professor Catharien Hilkens
| Hurdles in therapy with regulatory T cells | 2015 |
|
Dr Faye Cooles Dr Amy Anderson Professor Catharien Hilkens Professor John Isaacs
| The Interferon Gene Signature in Early Rheumatoid Arthritis Demonstrates No Significant Association with Disease Activity | 2015 |
|
Harriet Purvis Dr Amy Anderson Professor David Young Professor John Isaacs Professor Catharien Hilkens et al. | A Negative Feedback Loop Mediated by STAT3 Limits Human Th17 Responses | 2014 |
|
Dr Gillian Bell Dr Amy Anderson Julie Diboll Dr Rachel Harry Emerita Professor Elaine McColl et al. | Autologous Tolerogenic Dendritic Cells for Rheumatoid and Inflammatory Arthritis. | 2014 |
|
Dr Gillian Bell Dr Amy Anderson Dr Rachel Harry Julie Diboll Emerita Professor Elaine McColl et al. | Autologous tolerogenic dendritic cells in rheumatoid and inflammatory arthritis | 2014 |
|
Dr Nicola Maney Dr Gary Reynolds Dr Anja Krippner-Heidenreich Professor Catharien Hilkens
| Dendritic Cell Maturation and Survival Are Differentially Regulated by TNFR1 and TNFR2 | 2014 |
|
Dr Gary Reynolds Dr Faye Cooles Professor John Isaacs Professor Catharien Hilkens
| Emerging immunotherapies for rheumatoid arthritis | 2014 |
|
Dr Katherine Crossland Professor Simon Pearce Dr Mario Abinun Professor Timothy Cheetham Professor Catharien Hilkens et al. | Role of Aire in the Induction of Human Tolerogenic Dendritic Cells | 2014 |
|
Dr Gillian Bell Dr Amy Anderson Julie Diboll Dr Rachel Harry Emerita Professor Elaine McColl et al. | Autologous Tolerogenic Dendritic Cells In Rheumatoid and Inflammatory Arthritis | 2013 |
|
Dr Naomi McGovern Dr Laura Jardine Harriet Purvis Professor Catharien Hilkens Professor Matthew Collin et al. | IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses | 2013 |
|
Dr Jeroen Stoop Chris Tibbitt Professor John Robinson Professor Catharien Hilkens
| The choice of adjuvant determines the cytokine profile of T cells in proteoglycan-induced arthritis but does not influence disease severity | 2013 |
|
Professor Catharien Hilkens Professor John Isaacs
| Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? | 2013 |
|
Dr Arthur Pratt Dr Daniel Swan Dr Sarah Richardson Gillian Wilson Professor Catharien Hilkens et al. | A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly anti-citrullinated peptide antibody-negative disease | 2012 |
|
Dr Gillian Bell Dr Amy Anderson Dr Rachel Harry Dr Jeroen Stoop Professor Catharien Hilkens et al. | Autologous tolerogenic dendritic cells in rheumatoid arthritis | 2012 |
|
Dr Joanna Collerton Dr Carmen Martin-Ruiz karen Davies Professor Catharien Hilkens Professor John Isaacs et al. | Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ Study | 2012 |
|
Harriet Purvis Dr Amy Anderson Professor Catharien Hilkens
| Human T helper 17 responses: the effect of T-cell density | 2012 |
|
Dr Amy Anderson Dr Alice Lorenzi Dr Arthur Pratt Thomas Wooldridge Julie Diboll et al. | Immunity 12 years after alemtuzumab in RA: CD5+ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses | 2012 |
|
Dr Arthur Pratt Dr Sarah Richardson Gillian Wilson Professor Catharien Hilkens Professor David Young et al. | A Transcriptional Profile Present in CD4+T-Cells of Patients with Undifferentiated Arthritis Predicts the Future Development of Seronegative Rheumatoid Arthritis and Implicates IL-6 in Disease Evolution | 2011 |
|
Dr Carmen Martin-Ruiz Emerita Professor Carol Jagger Dr Andrew Kingston Dr Joanna Collerton Professor Mike Catt et al. | Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study | 2011 |
|
Dr Jeroen Stoop Professor John Robinson Professor Catharien Hilkens
| Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models? | 2011 |
|
Harriet Purvis Dr Amy Anderson Professor Catharien Hilkens
| Human Th17 responses: the effect of T-cell density | 2011 |
|
Dr Malcolm Brodlie Dr Michael McKean Dr Amy Anderson Professor Catharien Hilkens Professor Andrew Fisher et al. | Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease | 2011 |
|
Professor Catharien Hilkens Professor John Isaacs
| Development of dendritic cell-based immunotherapy for autoimmunity | 2010 |
|
Dr Rachel Harry Dr Amy Anderson Professor John Isaacs Professor Catharien Hilkens
| Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis | 2010 |
|
Harriet Purvis Dr Jeroen Stoop Professor Jelena Mann Steven Woods Anne Kozijn et al. | Low strength T-cell activation promotes Th17 responses | 2010 |
|
Dr Jeroen Stoop Professor Jelena Mann Steven Woods Anne Kozijn Professor Sophie Hambleton et al. | Low-strength T-cell activation promotes Th17 responses | 2010 |
|
Dr Arthur Pratt Dr Daniel Swan Dr Sarah Richardson Professor Catharien Hilkens Professor David Young et al. | Peripheral Blood CD4 T Cell Gene Expression Profiles as Predictive Biomarkers in Early Arthritis | 2010 |
|
Dr Nicola Maney Helen Baldwin Dr Anja Krippner-Heidenreich Professor Catharien Hilkens
| Regulation of dendritic cell survival and function by tumour necrosis factor receptors 1 and 2 | 2010 |
|
Dr Jeroen Stoop Professor John Robinson Professor Catharien Hilkens
| The choice of adjuvant determines the cytokine profile of T cells in proteoglycan induced arthritis | 2010 |
|
Dr Jeroen Stoop Dr Rachel Harry Dr Alexei von Delwig Professor John Isaacs Professor John Robinson et al. | Therapeutic Effect of Tolerogenic Dendritic Cells in Established Collagen-Induced Arthritis Is Associated With a Reduction in Th17 Responses | 2010 |
|
Helen Baldwin Dr Toshiko Ihara Professor John Isaacs Professor Catharien Hilkens
| Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritis | 2010 |
|
Dr Arthur Pratt Dr Daniel Swan Professor David Young Professor Catharien Hilkens Professor John Isaacs et al. | A High-Throughput Transcriptomics Approach to Biomarker Discover in Early Arthritis | 2009 |
|
Dr Rachel Lakey Emeritus Professor Drew Rowan Professor John Isaacs Emeritus Professor Tim Cawston Professor Catharien Hilkens et al. | A novel paradigm for dendritic cells as effectors of cartilage destruction | 2009 |
|
Dr Malcolm Brodlie Professor Catharien Hilkens Professor Christopher Ward
| Airway epithelial cells as guardians of immune homeostasis? | 2009 |
|
Professor Christopher Ward Julie Diboll Professor Andrew Fisher Dr Malcolm Brodlie Dr James Lordan et al. | Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells | 2009 |
|
Professor Muzlifah Haniffa Dr Xiao Wang Dr Venetia Bigley Ian Dimmick Dr Trevor Booth et al. | Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation | 2009 |
|
Dr Amy Anderson Dr David Swan Bethan Sayers Dr Rachel Harry Dr Angela Patterson et al. | LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells | 2009 |
|
Dr Xiao Wang Dr Udo Holtick Professor Matthew Collin Professor Graham Jackson Professor Catharien Hilkens et al. | Regulatory T-Cell Suppression of CD8+ T-Cell-Mediated Graft-Versus-Host Reaction Requires Their Presence During Priming | 2009 |
|
Dr Rachel Harry Dr Amy Anderson Dr Graham Raftery Professor John Isaacs Professor Catharien Hilkens et al. | Development of clinical-grade tolerogenic dendritic cells for the treatment of rheumatoid arthritis | 2008 |
|
Dr Amy Anderson Bethan Sayers Professor Muzlifah Haniffa Dr David Swan Julie Diboll et al. | Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells | 2008 |
|
Dr Jeroen Stoop Dr Alexei von Delwig Professor John Isaacs Professor John Robinson Professor Catharien Hilkens et al. | Immunotherapy with tolerogenic dendritic cells inhibits the progression of collagen-induced arthritis | 2008 |
|
Dr Udo Holtick Dr Scott Marshall Dr Xiao Wang Professor Catharien Hilkens Professor Anne Dickinson et al. | Impact of Psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cells | 2008 |
|
Dr Xiao Wang Professor Muzlifah Haniffa Dr Udo Holtick Professor Catharien Hilkens Professor Anne Dickinson et al. | Naturally occurring regulatory T-cells suppress CD8+lymphocyte induced graft-versus-host reactions in an in vitro human GvHD model | 2008 |
|
Dr Amy Anderson Bethan Sayers Dr David Swan Professor John Isaacs Professor Catharien Hilkens et al. | Tolerogenic dendritic cell therapy for rheumatoid arthritis | 2008 |
|
Professor Muzlifah Haniffa Dr Xiao Wang Dr Udo Holtick Dr Michelle Rae Professor John Isaacs et al. | Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells | 2007 |
|
Bethan Sayers Professor Muzlifah Haniffa Julie Diboll Professor John Isaacs Professor Catharien Hilkens et al. | Generation of dexamethasone and vitamin D3-treated human monocyte-derived dendritic cells with tolerogenic properties | 2007 |
|
Dr Xiao Wang Dr Udo Holtick Suzanne Alshemali Professor Nick Reynolds Professor Anne Dickinson et al. | Human dermal broblasts ameliorate in vitro graft-versushost reactions and are functionally indistinguishable from bone marrow mesenchymal stromal cells | 2007 |
|
Dr Udo Holtick Professor Catharien Hilkens Dr Xiao Wang Professor Anne Dickinson
| Immature dendritic cells downregulate graft versus host reactions in the human skin explant model after co-culture with in vitro PUVA treated lymphocytes | 2007 |
|
Professor Muzlifah Haniffa Dr Xiao Wang Dr Udo Holtick Dr Daniel Swan Professor Anne Dickinson et al. | Mesenchymal stem cells and fibroblasts have similar immunoregulatory properties in vitro but distinct gene expression profiles: Implications for cellular therapy | 2007 |
|
Dr Amy Anderson Bethan Sayers Julie Diboll Professor John Isaacs Professor Catharien Hilkens et al. | Tolerogenic dendritic cells differentially modulate naïve and memory CD4+ T cells | 2007 |
|
Suzanne Alshemali Dr Xiao Wang Professor Catharien Hilkens Professor Muzlifah Haniffa Professor Anne Dickinson et al. | Dermal dendritic cells but not Langerhans cells stimulate lymphocytes in an in vitro model of cutaneous graft-versus-host disease | 2006 |
|
Dr Alexei von Delwig Professor Catharien Hilkens Professor John Isaacs Dr Helen Robertson Professor John Robinson et al. | Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice | 2006 |
|
Dr Udo Holtick Dr Scott Marshall Dr Xiao Wang Professor Catharien Hilkens Professor Anne Dickinson et al. | Investigating the role of dendritic cells in extracorporeal photopheresis using an in vitro model | 2006 |
|
Dr Udo Holtick Dr Scott Marshall Professor Muzlifah Haniffa Professor Catharien Hilkens Dr Xiao Wang et al. | Investigating the role of dendritic cells in extracorporeal photopheresis using an in vitro model | 2006 |
|
Dr Udo Holtick Dr Scott Marshall Dr Xiao Wang Professor Catharien Hilkens Professor Anne Dickinson et al. | Modulation of dendritic cells in a human in vitro model of extracorporeal photopheresis | 2006 |
|
Dr Udo Holtick Dr Scott Marshall Dr Xiao Wang Professor Catharien Hilkens Professor Anne Dickinson et al. | The fate of monocytes and monocyte-derived dendritic cells in an in vitro model of extracorporeal photopheresis | 2006 |
|
Dr Udo Holtick Dr Scott Marshall Professor Catharien Hilkens Dr Xiao Wang Professor Anne Dickinson et al. | Examining the role of dendritic cells in extracorporeal photopheresis using an in vitro model | 2005 |
|
Bethan Sayers Professor Muzlifah Haniffa Julie Diboll Professor John Isaacs Professor Catharien Hilkens et al. | Generation of dexamethasone and vitamin D3 treated human monocyte derived dendritic cells with tolerogenic properties | 2005 |
|
Professor Catharien Hilkens
| Sustained IL-12 Signaling Is Required for Th1 Development | 2004 |
|
Professor Catharien Hilkens
| α-type-1 polarized dendritic cells: A novel immunization tool with optimized CTL-inducing activity | 2004 |
|
Professor Catharien Hilkens
| Differential Responses to IFN-α Subtypes in Human T Cells and Dendritic Cells | 2003 |
|
Professor Catharien Hilkens
| Cell-type and Donor-specific Transcriptional Responses to Interferon-α: Use of customized gene arrays | 2002 |
|
Professor Catharien Hilkens
| A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130 | 2001 |
|
Professor Catharien Hilkens
| How to deal with polarized Th2 cells: exploring the Achilles' heel | 2001 |
|
Professor Catharien Hilkens
| IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression | 2001 |
|
Professor Catharien Hilkens
| Atopic allergy: a failure of antigen-presenting cells to properly polarize helper T cells? | 2000 |
|
Professor Catharien Hilkens
| Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells | 1999 |
|
Professor Catharien Hilkens
| T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal | 1999 |
|
Professor Catharien Hilkens
| The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy | 1999 |
|
Professor Catharien Hilkens
| High-level IL-12 production by human dendritic cells requires two signals | 1998 |
|
Professor Catharien Hilkens
| Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation | 1998 |
|
Professor Catharien Hilkens
| The role of antigen-presenting cells in the regulation of allergen-specific T cell responses | 1998 |
|
Professor Catharien Hilkens
| Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses | 1997 |
|
Professor Catharien Hilkens
| Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype | 1997 |
|
Professor Catharien Hilkens
| IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells | 1997 |
|
Professor Catharien Hilkens
| Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells | 1996 |
|
Professor Catharien Hilkens
| Accessory cell-derived interleukin-12 and prostaglandin E2 determine the level of interferon-gamma produced by activated human CD4+ T cells | 1996 |
|
Professor Catharien Hilkens
| CD30 expression does not discriminate between human Th1- and Th2-type T cells | 1996 |
|
Professor Catharien Hilkens
| Lack of IL-12 signaling in human allergen-specific Th2 cells | 1996 |
|
Professor Catharien Hilkens
| Modulation of T-cell cytokine secretion by accessory cell-derived products | 1996 |
|
Professor Catharien Hilkens
| Production and modulation of T-cell cytokines in atopic allergy | 1996 |
|
Professor Catharien Hilkens
| Reduced IL-12 production by monocytes upon ultraviolet-B irradiation selectively limits activation of T helper-1 cells | 1996 |
|
Professor Catharien Hilkens
| Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit | 1996 |
|
Professor Catharien Hilkens
| The role of accessory cell products in the regulation of T cell cytokine production | 1996 |
|
Professor Catharien Hilkens
| Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2 | 1995 |
|
Professor Catharien Hilkens
| Functional maturation of human naive T helper cells in the absence of accessory cells. Generation of IL-4-producing T helper cells does not require exogenous IL-4 | 1995 |
|
Professor Catharien Hilkens
| Considerations in compiling a database of clinical test images | 1992 |
|